SCHEMBL17833965

SCHEMBL17833965

CC(/C=C1\SC(=O)N(C(C)C)C1=O)=C\c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.62
MEN1 O00255 9/20 0.62
KMT2A Q03164 9/20 0.62
LMNA P02545 6/20 0.62
ALDH1A1 P00352 4/20 0.62
POLB P06746 3/20 0.62
GAA P10253 2/20 0.62
MAPK1 P28482 2/20 0.59
SAE1 Q9UBE0 1/20 0.59
UBA2 Q9UBT2 1/20 0.59
NPC1 O15118 2/20 0.57
HPGD P15428 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
MITF O75030 1/20 0.57
XBP1 P17861 1/20 0.57
HTT P42858 1/20 0.57
RAB9A P51151 1/20 0.57
GFER P55789 1/20 0.57
TP53 P04637 1/20 0.54
PAX8 Q06710 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13747071 0.84 MAPT (0.79) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL17833988 0.82 LMNA (0.64) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL1102002 0.80 ALDH1A1 (0.70) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL13852448 0.80 MAPT (0.77) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL13852447 0.79 MAPT (0.76) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL13657864 0.77 MAPT (1.00) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL2789751 0.77 MAPT (1.00) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL13852582 0.77 MAPT (1.00) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL8188651 0.76 MAPT (0.78) MAPTMEN1KMT2ALMNAPOLB
SCHEMBL13657865 0.74 MAPT (1.00) MAPTMEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048276-A9 MYC MODULATORS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-02-13 US disclosed
US-10017520-B2 Myc modulators and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-07-10 US disclosed
US-10017520-B2 Myc modulators and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-07-10 US disclosed
US-20160168165-A1 MYC MODULATORS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-06-16 US disclosed
US-20160168165-A1 MYC MODULATORS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-06-16 US disclosed
WO-2016094688-A1 FUSED 1,3-AZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168165-A1 MYC MODULATORS AND USES THEREOF MYC, MYCBP, MYCBP2 MAPT 2226/4885MEN1 336/4885KMT2A 1253/4885
US-20200048276-A9 MYC MODULATORS AND USES THEREOF MYC, MYCBP, MYCBP2 MAPT 2226/4885MEN1 336/4885KMT2A 1253/4885
US-10017520-B2 Myc modulators and uses thereof MYC, MYCBP, MYCBP2 MAPT 2226/4885MEN1 336/4885KMT2A 1253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.